{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:17Z","timestamp":1786997897248,"version":"build-2736575974"},"reference-count":98,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T00:00:00Z","timestamp":1531180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.vaccine.2018.06.068","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T10:00:16Z","timestamp":1530871216000},"page":"4861-4874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"PB","title":["Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean 2010\u20132015: A systematic review and a time series analysis"],"prefix":"10.1016","volume":"36","author":[{"given":"Clara In\u00e9s","family":"Agudelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"DeAntonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.06.068_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.068_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166736","article-title":"Impact and effectiveness of 10 and 13-valent pneumococcal conjugate vaccines on hospitalization and mortality in children aged less than 5 years in Latin American countries: a systematic review","author":"de Oliveira","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.06.068_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(17)30110-8","article-title":"Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study","author":"Savulescu","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2018.06.068_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.068_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2014.08.009","article-title":"Decline in antibiotic resistance and changes in the serotype distribution of Streptococcus pneumoniae isolates from children with acute otitis media; a 2001\u20132011 survey by the French Pneumococcal Network","author":"Kempf","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2018.06.068_b0030","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0000000000000717","article-title":"The efficacy and duration of protection of pneumococcal conjugate vaccines against nasopharyngeal carriage: a meta-regression model","author":"Le Polain De Waroux","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.06.068_b0035","doi-asserted-by":"crossref","DOI":"10.3201\/eid1907.121830","article-title":"Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.)","author":"Richter","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.068_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001517","article-title":"Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites","author":"Feikin","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2018.06.068_b0045","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2008-1702","article-title":"Serotype 19A is the most common serotype causing invasive pneumococcal infections in children","author":"Kaplan","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2018.06.068_b0050","doi-asserted-by":"crossref","DOI":"10.3201\/eid1402.070807","article-title":"Streptococcus pneumoniae serotype 19A in children, South Korea","author":"Choi","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.068_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2017.02.005","article-title":"Changing trends in serotypes of S. pneumoniae isolates causing invasive and non-invasive diseases in unvaccinated population in Mexico (2000\u20132014)","author":"Carnalla-Barajas","year":"2017","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.068_b0060","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-12-124","article-title":"Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean: a systematic review and meta-analysis, 1990\u20132010","author":"Casta\u00f1eda","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.068_b0065","doi-asserted-by":"crossref","DOI":"10.1586\/14760584.2016.1166961","article-title":"Pneumococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned","author":"de Oliveira","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2018.06.068_b0070","unstructured":"Tan TQ. Otitis media and otitis externa. In: McInerny TK, Adam HM, Campbell DE, DeWitt TG, Foy JM, Kamat DM, editors. American Academy of pediatrics textbook of pediatrics care, 2nd ed. American Academy of Pediatrics; 2016. <https:\/\/pediatriccare.solutions.aap.org\/chapter.aspx?sectionid=136093981&bookid=1626> [accessed Dec 2016] [chapter 305]."},{"key":"10.1016\/j.vaccine.2018.06.068_b0075","unstructured":"World Health Organization. Measuring impact of Streptococcus pneumoniae and Haemophilus influenzae type b conjugate vaccination; 2012. <http:\/\/apps.who.int\/iris\/bitstream\/10665\/75835\/1\/WHO_IVB_12.08_eng.pdf> [accessed Dec 2016]."},{"key":"10.1016\/j.vaccine.2018.06.068_b0080","unstructured":"Organizaci\u00f3n Panamericana de la Salud. Informe Regional de SIREVA II, 2010: datos por pa\u00eds y por grupos de edad sobre las caracter\u00edsticas de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis en procesos invasores; 2011. <http:\/\/www.paho.org\/hq\/index.php?option=com_docman&task=doc_download&gid=14772&Itemid=270&lang=es> [accessed Sep 2016]."},{"key":"10.1016\/j.vaccine.2018.06.068_b0085","unstructured":"Organizaci\u00f3n Panamericana de la Salud. Informe Regional de SIREVA II, 2011: datos por pa\u00eds y por grupos de edad sobre las caracter\u00edsticas de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis en procesos invasores, 2011; 2012. <http:\/\/www.paho.org\/hq\/index.php?option=com_docman&task=doc_download&gid=19210&Itemid=270&lang=es> [accessed Sep 2016]."},{"key":"10.1016\/j.vaccine.2018.06.068_b0090","unstructured":"Organizaci\u00f3n Panamericana de la Salud. Informe Regional de SIREVA II, 2012: datos por pa\u00eds y por grupos de edad sobre las caracter\u00edsticas de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis en procesos invasores; 2013. <http:\/\/www.paho.org\/hq\/index.php?option=com_docman&task=doc_download&gid=22372&Itemid=270&lang=es> [accessed Sep 2016]."},{"key":"10.1016\/j.vaccine.2018.06.068_b0095","unstructured":"Organizaci\u00f3n Panamericana de la Salud. Informe regional de SIREVA II, 2013. Datos por pa\u00eds y por grupos de edad sobre las caracter\u00edsticas de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis, en procesos invasivos bacterianos; 2016. <http:\/\/iris.paho.org\/xmlui\/bitstream\/handle\/123456789\/31147\/9789275319185-spa.pdf?ua=1> [accessed Sep 2016]."},{"key":"10.1016\/j.vaccine.2018.06.068_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies","author":"Von Elm","year":"2014","journal-title":"Int J Surg"},{"key":"10.1016\/j.vaccine.2018.06.068_b0105","author":"United Nations, Department of Economic and Social Affairs, Population Division"},{"key":"10.1016\/j.vaccine.2018.06.068_b0110","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/1536867X1501500208","article-title":"Conducting interrupted time-series analysis for single- and multiple-group comparisons","volume":"15","author":"Linden","year":"2015","journal-title":"Stata J"},{"key":"10.1016\/j.vaccine.2018.06.068_b0115","doi-asserted-by":"crossref","unstructured":"PAHO. Coverage in the Americas by country. <http:\/\/www.paho.org\/hq\/index.php?option=com_topics&view=readall&cid=7342&Itemid=40929&lang=es> [accessed Dec 2016]. Moher D, Liberati A, Tetzlaff J, Altman DG for the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009. http:\/\/doi.org\/10.1136\/bmj.b2535.","DOI":"10.1136\/bmj.b2535"},{"key":"10.1016\/j.vaccine.2018.06.068_b0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2018.06.068_b0125","unstructured":"Instituto de Salud P\u00fablica de Chile. Comportamiento de Streptococcus pneumoniae serotipos 3 y 19 A en Chile, a\u00f1os 2007\u20132015; 2016. <http:\/\/www.ispch.cl\/content\/23172> [accessed Sep 2016]."},{"key":"10.1016\/j.vaccine.2018.06.068_b0130","unstructured":"Instituto Nacional de Salud P\u00fablica. Reporte de serotipos y susceptibilidad antimicrobiana de S. pneumoniae, H. influenzae y S. aureus; 2016. <http:\/\/www.insp.mx\/lineas-de-investigacion\/medicamentos-en-salud-publica\/sireva.html> [accessed Jan 2017]."},{"key":"10.1016\/j.vaccine.2018.06.068_b0135","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1016\/j.vaccine.2012.03.054","article-title":"Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Bogot\u00e1, Colombia","volume":"30","author":"Benavides","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.068_b0140","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1016\/j.vaccine.2012.05.054","article-title":"Hospitalized children with pneumonia in Uruguay: pre-and post-introduction of 7 and 13-valent pneumococcal conjugated vaccines into the National Immunization Program","volume":"30","author":"Hortal","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.068_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2012.12.005","article-title":"Prevalence of pneumococcal disease, serotype distribution, and antimicrobial susceptibility in Mexican children younger than 5 years of age","author":"Bautista-M\u00e1rquez","year":"2013","journal-title":"Arch Med Res"},{"key":"10.1016\/j.vaccine.2018.06.068_b0150","first-page":"101","article-title":"Neumon\u00eda necrotizante en ni\u00f1os hospitalizados en el hospital pedi\u00e1trico Centro Hospitalario Pereira Rossell en el a\u00f1o 2010\/Necrotizing pneumonia in children hospitalized at children's hospital Centro Hospitalario Pereira Rossell Hospital in 2010","volume":"84","author":"Machado","year":"2013","journal-title":"Arch Pediatr Urug"},{"key":"10.1016\/j.vaccine.2018.06.068_b0155","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1016\/j.vaccine.2013.04.074","article-title":"Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogot\u00e1, Colombia","volume":"31","author":"Parra","year":"2013","journal-title":"Vaccine"},{"issue":"Supplement 3","key":"10.1016\/j.vaccine.2018.06.068_b0160","doi-asserted-by":"crossref","first-page":"C109","DOI":"10.1016\/j.vaccine.2013.01.059","article-title":"Effectiveness of the 7-valent pneumococcal conjugate vaccine against vaccine-type invasive disease among children in Uruguay: an evaluation using existing data","volume":"31","author":"Pic\u00f3n","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.068_b0165","first-page":"27","article-title":"Serotype distribution of pneumococci isolated from pediatric patients with acute otitis media and invasive infections, and potential coverage of pneumococcal conjugated vaccines","volume":"45","author":"Reijtman","year":"2013","journal-title":"Rev Argent Microbiol"},{"key":"10.1016\/j.vaccine.2018.06.068_b0170","article-title":"Nineteen-years of pneumococcal invasive disease surveillance in a children's hospital in Mendoza, Argentina","author":"Abate","year":"2014","journal-title":"Arch Argent Pediatr"},{"key":"10.1016\/j.vaccine.2018.06.068_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(14)70060-8","article-title":"Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study","author":"Domingues","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2018.06.068_b0180","doi-asserted-by":"crossref","first-page":"266","DOI":"10.21149\/spm.v56i3.7344","article-title":"Prevalence of Streptococcus pneumoniae serotype 19A before and after the introduction of the heptavalent conjugate vaccine in Mexico","volume":"56","author":"Ech\u00e1niz-Avil\u00e9s","year":"2014","journal-title":"Salud P\u00fablica Mex"},{"key":"10.1016\/j.vaccine.2018.06.068_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112337","article-title":"Effect of pneumococcal conjugate vaccination in Uruguay, a middle-income country","author":"Garc\u00eda Gabarrot","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.06.068_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098567","article-title":"Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay","author":"Hortal","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.06.068_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.vacun.2014.09.002","article-title":"Conjugate vaccines and pneumococcal disease in Ecuador [Las vacunas conjugadas y la enfermedad neumoc\u00f3cica en Ecuador]","author":"Ortiz-Prado","year":"2014","journal-title":"Vacunas"},{"key":"10.1016\/j.vaccine.2018.06.068_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084993","article-title":"Serotype and genotype distribution among invasive Streptococcus pneumoniae isolates in Colombia, 2005\u20132010","author":"Parra","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.06.068_b0205","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0000000000000294","article-title":"Changes in hospitalizations for pneumonia after universal vaccination with pneumococcal conjugate vaccines 7\/13 valent and Haemophilus influenzae type b conjugate vaccine in a Pediatric Referral Hospital in Uruguay","author":"P\u00edrez","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.06.068_b0210","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.vaccine.2013.12.024","article-title":"Characterization of Streptococcus pneumoniae invasive serotype 19A isolates recovered in Colombia","volume":"32","author":"Ramos","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.068_b0215","first-page":"117","article-title":"Serotipos y resistencia antimicrobiana de aislamientos men\u00edngeos de Streptococcus pneumoniae. Cuba, 2007-2012","volume":"23","author":"Tora\u00f1o-Peraza","year":"2014","journal-title":"VacciMonitor"},{"key":"10.1016\/j.vaccine.2018.06.068_b0220","doi-asserted-by":"crossref","DOI":"10.4067\/S0716-10182014000600002","article-title":"Laboratory surveillance of Streptococcus pneumoniae from invasive disease, Chile 2007\u20132012","author":"Valenzuela","year":"2014","journal-title":"Rev Chilena Infectol"},{"key":"10.1016\/j.vaccine.2018.06.068_b0225","article-title":"Pneumococcal invasive disease in newborns before and after 7-valent and 13-valent universal pneumococcal vaccination in Uruguay","author":"Assandri","year":"2015","journal-title":"Rev Chilena Infectol"},{"key":"10.1016\/j.vaccine.2018.06.068_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2015.02.004","article-title":"Streptococcus pneumoniae serotypes identified in Mexican children with invasive disease before and after the introduction of PCV7 (1993\u20132012)","author":"Ech\u00e1niz-Avil\u00e9s","year":"2015","journal-title":"Arch Med Res"},{"key":"10.1016\/j.vaccine.2018.06.068_b0235","first-page":"502","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of consolidated pneumonia in children younger than 5 years old in Pilar, Buenos Aires: a population-based study","volume":"113","author":"Gentile","year":"2015","journal-title":"Arch Argent Pediatr"},{"key":"10.1016\/j.vaccine.2018.06.068_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jped.2014.07.002","article-title":"Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine","author":"Hirose","year":"2015","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.vaccine.2018.06.068_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjid.2015.10.005","article-title":"Clinical and bacteriological characteristics of invasive pneumococcal disease after pneumococcal 10-valent conjugate vaccine implementation in Salvador, Brazil","author":"Leite","year":"2016","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.068_b0250","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1016\/j.vaccine.2015.10.007","article-title":"Indirect cohort analysis of 10-valent pneumococcal conjugate vaccine effectiveness against vaccine-type and vaccine-related invasive pneumococcal disease","volume":"33","author":"Verani","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.068_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2015.12.001","article-title":"Streptococcus pneumoniae as cause of infection in infants less than 60 days of age: serotypes and antimicrobial susceptibility","author":"Soto-Noguer\u00f3n","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.068_b0260","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1590\/S0036-36342010000500006","article-title":"Invasive pneumococcal disease in a third level pediatric hospital in Mexico City: epidemiology and mortality risk factors","volume":"52","author":"G\u00f3mez-Barreto","year":"2010","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.vaccine.2018.06.068_b0265","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1590\/S1020-49892010000800008","article-title":"Invasive pneumococcal diseases among hospitalized children in Lima, Peru","volume":"28","author":"Ochoa","year":"2010","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.vaccine.2018.06.068_b0270","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.vaccine.2010.12.021","article-title":"Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae prior to introduction of the 10-valent pneumococcal conjugate vaccine in Brazil, 2000-2007","volume":"29","author":"de O Menezes","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.068_b0275","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.vaccine.2012.01.047","article-title":"Prospective epidemiologic surveillance of invasive pneumococcal disease and pneumonia in children in San Jos\u00e9, Costa Rica","volume":"30","author":"Arguedas","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.068_b0280","doi-asserted-by":"crossref","first-page":"6150","DOI":"10.1016\/j.vaccine.2013.05.042","article-title":"Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation","volume":"31","author":"dos Santos","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.068_b0285","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1016\/j.vaccine.2013.07.054","article-title":"Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations","volume":"31","author":"Hackel","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.068_b0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111129","article-title":"Serotypes and genotypes of invasive Streptococcus pneumoniae before and after PCV10 implementation in southern Brazil","author":"Caier\u00e3o","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.06.068_b0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001657","article-title":"Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: a double-blind randomized controlled trial","author":"Tregnaghi","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2018.06.068_b0300","doi-asserted-by":"crossref","DOI":"10.1177\/2051013614547199","article-title":"Early trends in invasive pneumococcal disease in children following the introduction of 13-valent pneumococcal conjugate vaccine: results from eight years of active surveillance in a Mexican hospital","author":"Chac\u00f3n-Cruz","year":"2014","journal-title":"Ther Adv Vaccines"},{"key":"10.1016\/j.vaccine.2018.06.068_b0305","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-015-1049-y","article-title":"Temporal trends and clonal diversity of penicillin non-susceptible pneumococci from meningitis cases from 1996 to 2012, in Salvador, Brazil","author":"dos Santos","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.068_b0310","first-page":"A2629","article-title":"Hospitalizations due to complicated pneumonia with parapneumonic pleural effusion or empyema in Costa Rican children: a 9-year study","volume":"191","author":"Vargas-Gutierrez","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2018.06.068_b0315","first-page":"207","article-title":"Streptococcus pneumoniae serotypes isolated from the middle ear of Mexican children diagnosed with acute otitis media","volume":"53","author":"G\u00f3mez-Barreto","year":"2011","journal-title":"Salud P\u00fablica Mex"},{"key":"10.1016\/j.vaccine.2018.06.068_b0320","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1016\/j.vaccine.2011.04.128","article-title":"Bacterial etiology and serotypes of acute otitis media in Mexican children","volume":"29","author":"Parra","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.068_b0325","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-11-4","article-title":"Non-typeable Haemophilus influenzae and Streptococcus pneumoniae as primary causes of acute otitis media in Colombian children: a prospective study","author":"Sierra","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.068_b0330","author":"Abdelnour","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.vaccine.2018.06.068_b0335","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1590\/S0036-36342010000100003","article-title":"Streptococcus pneumoniae serotype replacement in nasopharyngeal colonization in children vaccinated with PCV7 in Mexico","volume":"52","author":"Espinosa-de Los Monteros","year":"2010","journal-title":"Salud P\u00fablica Mex"},{"key":"10.1016\/j.vaccine.2018.06.068_b0340","doi-asserted-by":"crossref","DOI":"10.1007\/s10096-010-1044-6","article-title":"Epidemiology of Streptococcus pneumoniae and Staphylococcus aureus colonization in healthy Venezuelan children","author":"Quintero","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.068_b0345","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00242-11","article-title":"Genetic diversity of Tn916-related transposons among drug-resistant Streptococcus pneumoniae isolates colonizing healthy children in Venezuela","author":"Quintero","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2018.06.068_b0350","doi-asserted-by":"crossref","DOI":"10.1007\/s10096-011-1247-5","article-title":"Carriage and invasive isolates of Streptococcus pneumoniae in Caracas, Venezuela: the relative invasiveness of serotypes and vaccine coverage","author":"Rivera-Olivero","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.068_b0355","first-page":"S445","article-title":"The dynamics of Streptococcus pneumoniae nasopharyngeal carriage in mothers and children of the Warao Amerindians from Venezuela","volume":"17","author":"Sisco","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2018.06.068_b0360","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1590\/S1726-46342012000100008","article-title":"Pneumococcal serotypes in carrier children prior to the introduction of anti-pneumococcal vaccines in Peru","volume":"29","author":"Mercado","year":"2012","journal-title":"Rev Peru Med Exp Salud P\u00fablica"},{"key":"10.1016\/j.vaccine.2018.06.068_b0365","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-13-318","article-title":"Nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among children from Brazil before the introduction of the 10-valent conjugate vaccine","author":"Neves","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.068_b0370","doi-asserted-by":"crossref","DOI":"10.4236\/wjv.2013.32007","article-title":"Streptococcus pneumoniae upper respiratory carriage in Costa Rican children with otitis media before the introduction of the heptavalent conjugated vaccine in the national immunization program","author":"Ulloa","year":"2013","journal-title":"World J Vaccines"},{"key":"10.1016\/j.vaccine.2018.06.068_b0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098128","article-title":"Direct effect of 10-valent conjugate pneumococcal vaccination on pneumococcal carriage in children Brazil","author":"Andrade","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.06.068_b0380","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciu148","article-title":"The role of influenza and parainfluenza infections in nasopharyngeal pneumococcal acquisition among young children","author":"Grijalva","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.068_b0385","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1016\/j.vaccine.2014.04.027","article-title":"Immunogenicity of a 7-valent pneumococcal conjugate vaccine (PCV7) and impact on carriage in Venezuelan children at risk of invasive pneumococcal diseases","volume":"32","author":"Rivera-Olivero","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.068_b0390","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.vaccine.2015.12.042","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae among children in an urban setting in Brazil prior to PCV10 introduction","volume":"34","author":"Menezes","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.068_b0395","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing: twenty-fifth informational supplement. CLSI document M100-S25. Wayne, PA: Clinical and Laboratory Standards Institute; 2015."},{"key":"10.1016\/j.vaccine.2018.06.068_b0400","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1016\/j.vaccine.2010.03.069","article-title":"Surveillance of invasive pneumococcal disease in 30 EU countries: towards a European system?","volume":"28","author":"Hanquet","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.068_b0405","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2015.20.10.21057","article-title":"Impact of 10- and 13-valent pneumococcal conjugate vaccines on incidence of invasive pneumococcal disease in children aged under 16 years in Germany, 2009 to 2012","author":"Weiss","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2018.06.068_b0410","doi-asserted-by":"crossref","DOI":"10.3201\/eid2111.140780","article-title":"Invasive pneumococcal disease 3 years after introduction of 10-valent pneumococcal conjugate vaccine, the Netherlands","author":"Knol","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.068_b0415","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/cid\/civ368","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in US children","volume":"61","author":"Olarte","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.068_b0420","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","article-title":"Segmented regression analysis of interrupted time series studies in medication use research","volume":"27","author":"Wagner","year":"2002","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.vaccine.2018.06.068_b0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177113","article-title":"Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: a systematic review and meta-analysis","volume":"12","author":"Balsells","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.06.068_b0430","unstructured":"Organizaci\u00f3n Panamericana de la Salud. Informe regional de SIREVA II, 2014. Datos por pa\u00eds y por grupos de edad sobre las caracter\u00edsticas de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis, en procesos invasivos bacterianos; 2016. <http:\/\/iris.paho.org\/xmlui\/bitstream\/handle\/123456789\/33875\/9789275319420-spa.pdf?ua=1> [accessed Sep 2016]."},{"key":"10.1016\/j.vaccine.2018.06.068_b0435","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2015.1117713","article-title":"Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: a time-series analysis","author":"Andrade","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2018.06.068_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.tim.2011.06.001","article-title":"Risk of red queen dynamics in pneumococcal vaccine strategy","author":"Jefferies","year":"2011","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2018.06.068_b0445","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciw357","article-title":"Clinical and epidemiological evidence of the red queen hypothesis in pneumococcal serotype dynamics","author":"Stockmann","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.068_b0450","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01778-16","article-title":"Emergence of multidrug-resistant pneumococcal serotype 35B among children in the United States","author":"Olarte","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2018.06.068_b0455","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1016\/j.vaccine.2015.04.005","article-title":"Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada","volume":"33","author":"Deceuninck","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.068_b0460","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.vaccine.2016.02.043","article-title":"Vaccine effectiveness of PCV13 in a 3+1 vaccination schedule","volume":"34","author":"Weinberger","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.068_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(16)00052-7","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study","author":"Moore","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2018.06.068_b0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120290","article-title":"Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children \u2013 a population based study","author":"Jokinen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.06.068_b0475","unstructured":"World Health Organization. Measuring impact of Streptococcus pneumoniae and Haemophilus influenzae type b conjugate vaccination; 2012. <http:\/\/apps.who.int\/iris\/bitstream\/10665\/75835\/1\/WHO_IVB_12.08_eng.pdf> [accessed Dec 2016]."},{"key":"10.1016\/j.vaccine.2018.06.068_b0480","unstructured":"World Health Organization. Guidance for the development of evidence-based vaccine related recommendations; 2017. <http:\/\/www.who.int\/immunization\/sage\/Guidelines_development_recommendations.pdf> [accessed Dec 2016]."},{"key":"10.1016\/j.vaccine.2018.06.068_b0485","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1016\/j.vaccine.2013.07.006","article-title":"Vaccine effects and impact of vaccination programmes in post-licensure studies","volume":"31","author":"Hanquet","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.068_b0490","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1016\/j.vaccine.2014.04.019","article-title":"Vaccine preventable disease incidence as a complement to vaccine efficacy for setting vaccine policy","volume":"32","author":"Gessner","year":"2014","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18309095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18309095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:25:56Z","timestamp":1759400756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18309095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":98,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0264410X18309095"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.068","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean 2010\u20132015: A systematic review and a time series analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 GlaxoSmithKline Biologicals SA. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}